Tezepelumab was linked to significantly reduced nasal polyp size and nasal congestion vs placebo in adults with severe CRSwNP.

In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...

University of Florida scientists have helped identify a novel drug compound that selectively activates pain-altering ...

Current list price: GLP-1 medications range from $855 to $1,349.02 per month, depending on the medication, dose, and pharmacy. The out-of-pocket cost can vary depending on what insurance covers.

AZ is hoping that Fasenra (benralizumab) could join rival drugs from Sanofi/Regeneron and GlaxoSmithKline as approved therapies for chronic rhinosinusitis with nasal polyps (CRSwNP) that have been ...

"I wish I had known that to begin with," she says. "I would have stuck with water." The Food and Drug Administration (FDA) estimates that as many as half the people taking medications at any given ...

However, the role of IL-33 in chronic rhinosinusitis with nasal polyps (CRSwNP) remains unclear. Objective To investigate the role of IL-33 in the pathophysiology of CRSwNP. Methods We investigated IL ...